News | Hygieia

The d-Nav Program Featured on WXYZ TV

Two thirds of people who take insulin for type 2 diabetes do not have their blood sugar in the desired range. Andrea Isom from WXYZ TV 7 in Detroit talked with Hygieia CEO and Co-Founder Eran Bashan and d-Nav patient Marty Cook to find out how the d-Nav technology helps Marty, and potentially millions of […]

Why Metformin?

By Israel Hodish, M.D., Ph.D., co-founder and clinical research lead Most of the 30 million patients with type 2 diabetes in the United States have used metformin during the early stages of their disease. It is an oral medication used as first-line drug for type 2 diabetes.  What is metformin? Metformin is a synthetic modification […]

Five Diabetes Myths That Must Go!

By Robin Johnson, BSN, RN, CDCES Clinical Liaison, Hygieia In my 16 years as a certified diabetes educator, I’ve worked with many people newly diagnosed with type 2 diabetes, and their families. There is much they don’t know about this complicated disease and much to be learned as we separate fact from fiction. Often, my […]

Hygieia adds to leadership team with newly created sales VP position

Increased sales expected for company’s AI-driven d-Nav® technology, which makes insulin therapy safe and effective for people with type 2 diabetes. Livonia, Michigan, May 18, 2021 – Hygieia, a digital health company for insulin therapy management, has appointed William Pruitt to the new position of vice president of sales. William joins Hygieia as it embarks […]

Patient regains eyesight, controls blood sugar with insulin management and AI-powered technology

“Diabetes took my eyesight!”   Nearly one million Michiganders struggle with type 2 diabetes. For many, it is a daily battle fought and lost at the most granular of levels: their blood sugar numbers. To April, in her early 20s when she was diagnosed with gestational diabetes, it was nearly a death sentence.  For 20 […]

Insulin’s Next Century: Technology’s role in unlocking the power of insulin

by Eran Bashan, Hygieia CEO and Co-founder One hundred years ago a group of Canadian scientists and physicians discovered insulin. Frederick Banting, J.R. Macleod, Charles Best and James Collip’s historic finding meant the difference between life and death for people with diabetes.  Nearly a century later, Hygieia co-founder Dr. Israel Hodish published a paper1 in […]

Diabetes discriminates: Why one’s ethnicity can impact the likelihood of developing type 2 diabetes and suffering from its complications

By Israel Hodish, M.D., Ph.D., co-founder and clinical research lead Type 2 diabetes affects about 10% of the general population in the United States. Yet, it occurs in nearly 15% of the Native-American population, nearly 12% of the non-Hispanic black population, and nearly 13% of the Hispanic population, according to the American Diabetes Association. Why […]

Hygieia adds to its clinical liaison team as more physicians embrace revolutionary d-Nav® technology

Hygieia has appointed Nikki Seeley as its newest clinical liaison. Nikki will be serving primary care physicians, endocrinologists, clinics and health systems throughout southeast and central Michigan with special focus on Oakland and Macomb counties, and Flint and Saginaw markets. She joins Hygieia as demand grows for the organization’s first-to-market d-Nav® Insulin Management Program. Seeley, […]

Healthcare services leader Ted Bucknam joins Hygieia as president, leading company’s expansion of clinical insulin management program

Demand grows for Hygieia’s d-Nav® program, a unique technology that makes insulin work better Livonia, Mich., March 23, 2021 – Hygieia, a digital health company for insulin therapy management, has appointed Ted Bucknam as president. Bucknam will spearhead the company’s clinical expansion, working with endocrinologists, referring physicians and clinic partners throughout Michigan and the U.S. […]

Insulin Therapy: The How and Why of Dose Changes

By Israel Hodish, M.D., Ph.D., co-founder and clinical research lead Most patients who use insulin therapy use it for type 2 diabetes. Type 2 diabetes is a progressive condition of insulin deficiency, which means that over time the body secretes less and less insulin. During the second decade of the disease, most patients require insulin […]